Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 8Active not recruiting 5Terminated 4Withdrawn 1Unknown 1Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 130Head & Neck 108Gastrointestinal 99Gynecologic 70Breast 23Lymphoid 19CNS 19Genitourinary 16Other solid neoplasm 15Tumor-Agnostic 9Dermatologic 5Endocrine 4Other hematologic neoplasm 3Sarcoma 2NET 2Plasma cell 1Myeloid 1

Conditions

Neoplasms, Plasma Cell 1Multiple Myeloma 1

Interventions

Dexamethasone 69Cyclophosphamide 43Bortezomib 40Lenalidomide 24Melphalan 22Thalidomide 19pomalidomide 17fludarabine 13daratumumab 13carfilzomib 10Doxorubicin 8Filgrastim 7Busulfan 6isatuximab 5Prednisone 5Peripheral Blood Stem Cell Transplantation 5Calcium Dobesilate 5Bendamustine Hydrochloride 5selinexor 4sargramostim 4fludarabine phosphate 4Surveys and Questionnaires 4Etoposide 4Clarithromycin 4liposomal doxorubicin 3ixazomib 3dexamethasone acetate 3Radiotherapy 3Neoadjuvant Therapy 3Mycophenolic Acid 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Cisplatin × Plasma cell × Clear all
NCT00004903 2014-01-06

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

National Cancer Institute (NCI)

Phase 2 Unknown
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡